ATE312100T1 - Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten - Google Patents

Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten

Info

Publication number: ATE312100T1
Authority: AT; Austria
Prior art keywords: optionally substituted; chain; substituted; denotes; represented
Prior art date: 1999-09-28

Application number

AT00962889T

Other languages

English (en)

Inventor

Toshimi Okada

Nobuyuki Kurusu

Keigo Tanaka

Kazuki Miyazaki

Daisuke Shinmyo

Hiroyuki Sugumi

Hironori Ikuta

Hironobu Hiyoshi

Takao Saeki

Mamoru Yanagimachi

Masashi Ito

Original Assignee

Eisai Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-09-28

Filing date

2000-09-27

Publication date

2005-12-15

2000-09-27 Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd

2005-12-15 Application granted granted Critical

2005-12-15 Publication of ATE312100T1 publication Critical patent/ATE312100T1/de

Links

239000004480 active ingredient Substances 0.000 title 1
229940079593 drug Drugs 0.000 title 1
239000003814 drug Substances 0.000 title 1
SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical class C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 title 1
YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 abstract 1
125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
125000003161 (C1-C6) alkylene group Chemical group 0.000 abstract 1
125000006590 (C2-C6) alkenylene group Chemical group 0.000 abstract 1
125000006591 (C2-C6) alkynylene group Chemical group 0.000 abstract 1
BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 abstract 1
229940125532 enzyme inhibitor Drugs 0.000 abstract 1
239000002532 enzyme inhibitor Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
125000004430 oxygen atom Chemical group O* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
229940031439 squalene Drugs 0.000 abstract 1
TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 abstract 1
229910052717 sulfur Inorganic materials 0.000 abstract 1
125000004434 sulfur atom Chemical group 0.000 abstract 1
230000002194 synthesizing effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Obesity (AREA)
Diabetes (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT00962889T 1999-09-28 2000-09-27 Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten ATE312100T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP27390599		1999-09-28
JP2000179352		2000-06-15
PCT/JP2000/006665 WO2001023383A1 (en)	1999-09-28	2000-09-27	Quinuclidine compounds and drugs containing the same as the active ingredient

Publications (1)

Publication Number	Publication Date
ATE312100T1 true ATE312100T1 (de)	2005-12-15

Family

ID=26550809

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT00962889T ATE312100T1 (de)	1999-09-28	2000-09-27	Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten

Country Status (20)

Country	Link
US (1)	US6599917B1 (de)
EP (1)	EP1217001B1 (de)
JP (1)	JP4206212B2 (de)
KR (1)	KR100694687B1 (de)
CN (1)	CN100334085C (de)
AT (1)	ATE312100T1 (de)
AU (1)	AU782114B2 (de)
BR (1)	BR0014331A (de)
CA (1)	CA2385995C (de)
DE (1)	DE60024651T2 (de)
DK (1)	DK1217001T3 (de)
ES (1)	ES2252063T3 (de)
HU (1)	HUP0203514A3 (de)
IL (2)	IL148631A0 (de)
MX (1)	MXPA02003167A (de)
NO (1)	NO328218B1 (de)
NZ (1)	NZ517788A (de)
RU (1)	RU2266905C2 (de)
TW (1)	TWI282794B (de)
WO (1)	WO2001023383A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0010955D0 (en) *	2000-05-05	2000-06-28	Novartis Ag	Organic compounds
US7112593B2 (en)	2001-03-27	2006-09-26	Eisai Co., Ltd.	N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient
EP1256573A1 (de)	2001-05-09	2002-11-13	Eisai Co., Ltd.	Verfahren zur Herstellung eines Stereoisomers von Pyrrolidinderivat
RU2004110717A (ru) *	2001-10-17	2005-10-20	Юсиби, С.А. (Be)	Производные хинуклидина, способы их получения и их применение в качестве и нгибиторов м2- и/или м3- мускариновых рецепторов
US7361671B2 (en) *	2001-11-15	2008-04-22	The Institute For Pharmaceutical Discovery, Inc.	Substituted heteroarylalkanoic acids
DE10225537A1 (de) *	2002-06-10	2003-12-18	Bayer Ag	N-alkylierte Thiazoliumsalze und Verfahren zu deren Herstellung
GB0218876D0 (en) *	2002-08-13	2002-09-25	Merck Sharp & Dohme	Therapeutic agents
AU2003276919B2 (en)	2002-09-25	2013-05-16	Memory Pharmaceuticals Corporation	Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
DE10334724A1 (de) *	2003-07-30	2005-02-24	Bayer Healthcare Ag	N-Biarylamide
US7432281B2 (en) *	2003-10-07	2008-10-07	Renovis, Inc.	Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
RU2417225C2 (ru)	2004-03-25	2011-04-27	Мемори Фармасьютиклз Корпорейшн	Индазолы, бензотиазолы, бензоизотиазолы, бензизоксазолы и их получение и применение
US8106066B2 (en)	2005-09-23	2012-01-31	Memory Pharmaceuticals Corporation	Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
CA2679198C (en)	2007-02-26	2011-07-12	Pfizer Products Inc.	Nicotinamide derivatives as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases
TW201111385A (en)	2009-08-27	2011-04-01	Biocryst Pharm Inc	Heterocyclic compounds as janus kinase inhibitors
US8420661B2 (en) *	2010-04-13	2013-04-16	Hoffmann-La Roche Inc.	Arylethynyl derivatives
CA2799926A1 (en)	2010-05-28	2011-12-01	Biocryst Pharmaceuticals, Inc.	Heterocyclic compounds as janus kinase inhibitors
DK3738434T3 (da)	2011-12-28	2023-12-04	Global Blood Therapeutics Inc	Mellemprodukter til opnåelse af substituerede benzaldehydforbindelser og fremgangsmåder til anvendelse deraf ved øgning af vævsoxygenering
WO2013102145A1 (en)	2011-12-28	2013-07-04	Global Blood Therapeutics, Inc.	Substituted heteroaryl aldehyde compounds and methods for their use in increasing tissue oxygenation
WO2014060381A1 (de)	2012-10-18	2014-04-24	Bayer Cropscience Ag	Heterocyclische verbindungen als schädlingsbekämpfungsmittel
CN104884449A (zh)	2012-10-31	2015-09-02	拜尔农作物科学股份公司	作为害虫防治剂的新的杂环化合物
US10100043B2 (en)	2013-03-15	2018-10-16	Global Blood Therapeutics, Inc.	Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US8952171B2 (en)	2013-03-15	2015-02-10	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US9458139B2 (en)	2013-03-15	2016-10-04	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
KR102280614B1 (ko)	2013-03-15	2021-07-21	글로벌 블러드 테라퓨틱스, 인크.	헤모글로빈 조정을 위한 화합물 및 이의 용도
US9422279B2 (en)	2013-03-15	2016-08-23	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en)	2013-03-15	2019-04-23	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en)	2013-03-15	2017-10-31	Global Blood Therapeutics, Inc.	Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
BR112015021982B1 (pt)	2013-03-15	2022-12-13	Global Blood Therapeutics, Inc	Compostos e seus usos para a modulação de hemoglobina
US20140274961A1 (en)	2013-03-15	2014-09-18	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en)	2013-03-15	2017-03-28	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
AU2014237330A1 (en)	2013-03-15	2015-09-17	Global Blood Therapeutics, Inc.	Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru)	2013-11-18	2020-06-30	Глобал Блад Терапьютикс, Инк.	Соединения и их применения для модуляции гемоглобина
SI3102208T2 (sl)	2014-02-07	2024-10-30	Global Blood Therapeutics, Inc.	Kristalinični polimorf proste baze 2-hidroksi-6-((2-(1-izopropil-1H-pirazol-5-IL)piridin-3-IL)metoksi)- benzaldehida
MA41841A (fr)	2015-03-30	2018-02-06	Global Blood Therapeutics Inc	Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
HRP20200638T1 (hr)	2015-06-03	2020-07-10	F. Hoffmann - La Roche Ag	Derivati etinila
US11020382B2 (en)	2015-12-04	2021-06-01	Global Blood Therapeutics, Inc.	Dosing regimens for 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde
AR108435A1 (es)	2016-05-12	2018-08-22	Global Blood Therapeutics Inc	Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
TWI778983B (zh)	2016-10-12	2022-10-01	美商全球血液治療公司	包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
WO2020061103A1 (en)	2018-09-18	2020-03-26	Nikang Therapeutics, Inc.	Fused tricyclic ring derivatives as src homology-2 phosphatase inhibitors
EP3860975B1 (de)	2018-10-01	2023-10-18	Global Blood Therapeutics, Inc.	Modulatoren von hämoglobin zur behandlung von sichelzellenanämie

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2105655A1 (en) *	1991-03-08	1992-09-09	Kent Neuenschwander	Multicyclic tertiary amine polyaromatic squalene synthetase inhibitors
US5135935A (en) *	1991-05-17	1992-08-04	Merck & Co., Inc.	Squalene synthetase inhibitors
GB9127279D0 (en)	1991-12-23	1992-02-19	Ici Plc	Heterocyclic derivatives
JPH05310732A (ja) *	1992-03-12	1993-11-22	Mitsubishi Kasei Corp	シンノリン−３−カルボン酸誘導体
GB9207961D0 (en)	1992-04-10	1992-05-27	Ici Plc	Heterocyclic derivatives
GB9218334D0 (en)	1992-08-28	1992-10-14	Ici Plc	Heterocyclic compounds
AU7394394A (en)	1992-10-13	1995-12-05	Rhone-Poulenc Rorer Pharmaceuticals Inc.	3-hydroxyquinuclidin-3-ylphenylquinolines as squalene synthase inhibitors
GB9226573D0 (en) *	1992-12-21	1993-02-17	Ici Plc	Heterocyclic compounds
IL109451A0 (en)	1993-04-29	1994-07-31	Zeneca Ltd	Heterocyclic derivatives
GB9412145D0 (en)	1994-06-17	1994-08-10	Zeneca Ltd	Heterocycles
JPH08134067A (ja)	1994-11-11	1996-05-28	Yamanouchi Pharmaceut Co Ltd	キヌクリジン誘導体
JPH08269056A (ja)	1995-03-29	1996-10-15	Chugai Pharmaceut Co Ltd	スクアレンシンセターゼ阻害作用を有するキヌクリジン誘導体
US5712270A (en) *	1995-11-06	1998-01-27	American Home Products Corporation	2-arylamidothiazole derivatives with CNS activity
JP2000511532A (ja)	1996-05-20	2000-09-05	メルクエンドカンパニーインコーポレーテッド	性腺刺激ホルモン放出ホルモンのアンタゴニスト

2000
- 2000-09-27 AT AT00962889T patent/ATE312100T1/de not_active IP Right Cessation
- 2000-09-27 DE DE60024651T patent/DE60024651T2/de not_active Expired - Lifetime
- 2000-09-27 ES ES00962889T patent/ES2252063T3/es not_active Expired - Lifetime
- 2000-09-27 HU HU0203514A patent/HUP0203514A3/hu unknown
- 2000-09-27 WO PCT/JP2000/006665 patent/WO2001023383A1/ja not_active Ceased
- 2000-09-27 MX MXPA02003167A patent/MXPA02003167A/es active IP Right Grant
- 2000-09-27 RU RU2002111344/04A patent/RU2266905C2/ru not_active IP Right Cessation
- 2000-09-27 EP EP00962889A patent/EP1217001B1/de not_active Expired - Lifetime
- 2000-09-27 IL IL14863100A patent/IL148631A0/xx unknown
- 2000-09-27 DK DK00962889T patent/DK1217001T3/da active
- 2000-09-27 CA CA002385995A patent/CA2385995C/en not_active Expired - Fee Related
- 2000-09-27 TW TW089119958A patent/TWI282794B/zh not_active IP Right Cessation
- 2000-09-27 BR BR0014331-6A patent/BR0014331A/pt not_active Application Discontinuation
- 2000-09-27 CN CNB00813541XA patent/CN100334085C/zh not_active Expired - Fee Related
- 2000-09-27 AU AU74464/00A patent/AU782114B2/en not_active Ceased
- 2000-09-27 US US10/088,554 patent/US6599917B1/en not_active Expired - Fee Related
- 2000-09-27 NZ NZ517788A patent/NZ517788A/en not_active IP Right Cessation
- 2000-09-27 JP JP2001526535A patent/JP4206212B2/ja not_active Expired - Fee Related
- 2000-09-27 KR KR1020027003952A patent/KR100694687B1/ko not_active Expired - Fee Related
2002
- 2002-03-12 IL IL148631A patent/IL148631A/en not_active IP Right Cessation
- 2002-03-26 NO NO20021528A patent/NO328218B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP1217001A4 (de)	2002-12-18
HUP0203514A2 (hu)	2003-03-28
ES2252063T3 (es)	2006-05-16
BR0014331A (pt)	2003-06-10
NZ517788A (en)	2003-11-28
EP1217001A1 (de)	2002-06-26
DE60024651T2 (de)	2006-09-28
CA2385995C (en)	2009-06-16
CA2385995A1 (en)	2001-04-05
AU7446400A (en)	2001-04-30
CN1377349A (zh)	2002-10-30
IL148631A0 (en)	2002-09-12
US6599917B1 (en)	2003-07-29
KR20020034197A (ko)	2002-05-08
JP4206212B2 (ja)	2009-01-07
DE60024651D1 (de)	2006-01-12
MXPA02003167A (es)	2003-10-06
AU782114B2 (en)	2005-07-07
HUP0203514A3 (en)	2004-01-28
NO20021528D0 (no)	2002-03-26
NO20021528L (no)	2002-05-28
DK1217001T3 (da)	2006-03-20
KR100694687B1 (ko)	2007-03-13
EP1217001B1 (de)	2005-12-07
IL148631A (en)	2010-04-29
NO328218B1 (no)	2010-01-11
WO2001023383A1 (en)	2001-04-05
CN100334085C (zh)	2007-08-29
TWI282794B (en)	2007-06-21
RU2266905C2 (ru)	2005-12-27

Legal Events

Date

Code

Title

Description

2006-08-15

UEP

Publication of translation of european patent specification

Ref document number: 1217001

Country of ref document: EP

2008-07-15

EEIH

Change in the person of patent owner

2011-06-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE60024651D1 (de)	2006-01-12	Chinuclidin-verbindungen und medikamente die diese als aktive wirkstoffe enthalten
DE60119894D1 (de)	2006-06-29	Piperidinverbindungen und diese enthaltenden medikamente
MXPA04001258A (es)	2005-06-06	Activador para el receptor d que responde al proliferador de peroxisoma.
ES2166359T3 (es)	2002-04-16	Derivado de depsipeptido, su produccion y uso.
EA200601830A1 (ru)	2007-04-27	Ортозамещённые арильные или гетероарильные амидные соединения
EP0976748A4 (de)	2001-08-08	Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
DE60012751D1 (de)	2004-09-09	Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz
AU8799201A (en)	2002-04-08	Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases
ATE279411T1 (de)	2004-10-15	Fluorszierende marker
DE60223904D1 (de)	2008-01-17	Benzylaminanalogen
EA200600570A1 (ru)	2006-12-29	Замещенные 2-карбониламино-6-пиперидинаминопиридины и замещенные 1-карбониламино-3-пиперидинаминобензолы как агонисты 5-ht
NO982873L (no)	1998-08-21	1-metylkarbapenemderivater
ATE366248T1 (de)	2007-07-15	N-aryl-substituiertes cyclisches aminderivat und medizin, die dieses als wirkstoff enthält
ES2129123T3 (es)	1999-06-01	Nuevo derivado de bisoxadiazolidina.
EA200100967A1 (ru)	2002-02-28	Новое иммунодепрессивное средство
EP1197211A4 (de)	2004-09-01	Wirkstoffe zur vorbeugung und behandlung von krebs
EP1000620A4 (de)	2004-03-17	Lp(a)MINDERE MITTEL UND INHIBITOREN DER APOPROTEIN (a) PRODUKTION
EA200001157A2 (ru)	2001-06-25	Новые замещенные производные (дигидро)бензоксазина и (дигидро)бензотиазина, способ их получения и содержащие их фармацевтические композиции
DE602005027246D1 (de)	2011-05-12	Mittel zur linderung von niereninsuffizienz
DE69622393D1 (de)	2002-08-22	Neue verwendung von pyrazolopyridinverbindungen
DE602004008338D1 (de)	2007-09-27	Substituierte (4-aminocyclohexen-1-yl) phenyl and (4-aminocyclohexen-1-yl) pyridinyl verbindungen als 5-ht1f agonisten